Current location - Trademark Inquiry Complete Network - Trademark inquiry - A list of Chinese medicine concept leading stocks
A list of Chinese medicine concept leading stocks

Overview of the concept of traditional Chinese medicine leading stocks 223

Traditional Chinese medicine can effectively treat COVID-19. In short, traditional Chinese medicine refers to substances that are used to prevent, treat and diagnose diseases and have rehabilitation and health care functions under the guidance of traditional Chinese medicine theory. So today, Xiaobian is here to sort out the list of leading stocks of traditional Chinese medicine. Let's take a look!

Zixin Pharmaceutical 2118

The main business of Jilin Zixin Pharmaceutical Co., Ltd. is Chinese patent medicine industry, ginseng industry and industrial hemp industry. The company's main products are pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, lozenges, ginseng products and industrial hemp products.

the company's "Zixin" trademarks are well-known trademarks in China and Jilin province. The company was rated as "Quality Unit in China Pharmaceutical Industry" and "Best Reputation Unit in Jilin Province"; "No fake units in China pharmaceutical industry"; "AAA China Credit Enterprise".

Darentang 6329

The main business of Tianjin Darentang Group Co., Ltd. is the R&D and manufacturing of Chinese patent medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutrition and health products and pharmaceutical commerce. The main products include cerebrovascular drugs, respiratory drugs, spleen and stomach drugs, cold drugs, tumor drugs, gynecological and pediatric drugs. The company now has 1 national enterprise technology center, 5 municipal enterprise technology centers, 1 enterprise key laboratory, 1 municipal modern technology engineering center and Post-Doctoral Research Center approved by the Ministry of Personnel.

the company is mainly committed to the research, development and production of traditional Chinese medicine products. It has 1 state secret variety (Quick-acting Jiuxin Pill), 2 state secret varieties (Niuhuang Jiangya Series), 18 protected varieties of traditional Chinese medicine, and 82 exclusively produced varieties. The sales volume of the leading product, Quick-acting Jiuxin Pill, exceeds 4 million yuan. The company has 59 registered varieties in 11 series and 21 dosage forms.

Darentang 6329

The main business of Tianjin Darentang Group Co., Ltd. is the R&D and manufacturing of Chinese patent medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutrition and health products and pharmaceutical commerce. The main products include cerebrovascular drugs, respiratory drugs, spleen and stomach drugs, cold drugs, tumor drugs, gynecological and pediatric drugs. The company now has 1 national enterprise technology center, 5 municipal enterprise technology centers, 1 enterprise key laboratory, 1 municipal modern technology engineering center and Post-Doctoral Research Center approved by the Ministry of Personnel.

The company owns six well-known trademarks in China, such as Darentang, Songbai, Lerentang, Longshunrong, Jingwanhong and Biqi, 12 famous trademarks, such as Great Wall, Tijian Tezi Shefu, Gushang Medicinal Liquor Workshop and Jianchun, and three old Chinese brands, such as Longshunrong, Darentang and Lerentang.

Fangsheng Pharmaceutical 63998

Hunan Fangsheng Pharmaceutical Co., Ltd. is a high-tech enterprise mainly engaged in the research, development, production and sales of cardiovascular and cerebrovascular Chinese patent medicines, orthopedic medicines, pediatric medicines, gynecological medicines, anti-infective medicines, etc. The main products are Xuesaitong dispersible tablets, Xuesaitong tablets, Teng Jian Huang bone tablets, traumatic huoxue capsule, lysine vitamin B12 granules, cefixime tablets, Jinying capsules and Pu.

Therefore, the company has been successively evaluated as a key high-tech enterprise in the National Torch Program, a national contract-abiding enterprise, a national Post-Doctoral Research Center, a national enterprise technology center, a top 1 most competitive enterprise in China pharmaceutical industry in 212, an AAA honest enterprise in China pharmaceutical industry in 212, an outstanding private enterprise in China, a top 5 pharmaceutical industry growth enterprise in China in 218, a national technological innovation demonstration enterprise and a top 1 manufacturing enterprise in Hunan in 219.